Thought Leaders to Meet in Baltimore for the 7th Annual Personalized & Precision Medicine Conference

This conference brings together payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic view of the precision medicine landscape.

News provided by

Arrowhead Publishers

Jun 30, 2015, 07:00 ET

MINNEAPOLIS, June 30, 2015 /PRNewswire/ -- Arrowhead's 7th Annual Personalized & Precision Medicine Conference is coming to Baltimore, MD on October 5-6, 2015 as an official satellite event to the American Society for Human Genetics Annual Meeting. This Conference will be an exciting opportunity to deliberate alongside various stakeholders and experts regarding the ways in which healthcare is being reshaped by personalized and precision medicine. This conference brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic view of the precision medicine landscape.

Key topics at this year's Conference include:
- Finding value in pharmacogenomics
- The challenge of adopting NGS panels
- Making RNA sequencing actionable in the clinic
- Integration of whole genome sequencing into clinical medicine
- Precision healthcare platforms
- Balancing public and private intellectual property interests in a post Mayo-Myriad age
- Precision medicine and policy in the making

Featured Speakers include:
Robert Green, MD, FACP, Director of Applied Genomics Research Informatics, Director, Health Heritage Family Medical History Project, Center for Biomedical Research Informatics at NorthShore University Research Institute
Gitte Pederson, Chief Executive Officer at Genomic Expression
Anya Schiess, MBA, General Partner and Co-Founder at Healthy Ventures
Paul Sheives, JD, Vice President, Reimbursement & Regulatory Policy at American Clinical Laboratory Association
Elaine Cheung, Director of Strategic Partnerships at Illumina
Angela Davies, MD, FRCP (C), Chief Medical Officer at Champions Oncology
Mark Gerstein, Ph.D., Professor of Biomedical Informatics at Yale University
Laura Lyman Rodriquez, Ph.D., Director, Office of Policy, Communications and Education at National Human Genome Research Institute
Jen Madsen, MPH, Health Policy Advisor at Arnold & Porter
Ken Ramos, MD, Ph.D., PharmB, Associate Vice President for Precision Health Sciences, Professor of Medicine at Arizona Health Sciences Center
Birgit Reitmaier, Ph.D., Head of Technologies & Biomarkers, Global Licensing & Business Development at Merck Serono division, Merck KGaA